195 related articles for article (PubMed ID: 30975166)
1. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients.
Yu H; Qu G; Wang Y; Mai W; Bao JJ; Song C; Yao M
J Orthop Surg Res; 2019 Apr; 14(1):103. PubMed ID: 30975166
[TBL] [Abstract][Full Text] [Related]
2. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of Eps15 Homology Domain 1 is Associated with Poor Prognosis in Resected Small Cell Lung Cancer.
Meng Q; Sun W; Li M; Zhao Y; Chen X; Sun L; Cai L
J Cancer; 2015; 6(10):990-5. PubMed ID: 26366212
[TBL] [Abstract][Full Text] [Related]
4. Expression of TGFβ-1 and EHD1 correlated with survival of non-small cell lung cancer.
Gao Y; Wang Y; Sun L; Meng Q; Cai L; Dong X
Tumour Biol; 2014 Sep; 35(9):9371-80. PubMed ID: 24946721
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
8. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
9. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
11. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
12. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
Zhu Y; Zhou J; Ji Y; Yu B
Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
[TBL] [Abstract][Full Text] [Related]
15. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
16. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
[TBL] [Abstract][Full Text] [Related]
17. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
[TBL] [Abstract][Full Text] [Related]
18. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
20. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]